Peptides are molecularly small molecules and represent a class of pharmaceutical compounds that are both biochemically and therapeutically separate from the proteins.
TFLL Pharma carries out the development of the equivalents of the products in this category in accordance with the current regulations. TFLL Pharma specializes in the following technological areas.
Biotechnological products are products produced from organisms and living systems using biological systems. This definition includes certain blood products, various immunological products and products obtained by recombinant DNA technology or monoclonal antibody methods.
Biosimilars are similar versions of the original biotechnological products produced after the patent expires. Biosimilar drugs are products similar to original drugs in terms of biological product.
TFLL Pharma provides consultancy services to its customers in accordance with the current regulations for the development of the products in this category.